Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -3.581% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COc1ccc(C2CC(=O)C(C=NCCN3CCN(C(C)=O)CC3)=C(O)C2)cc1
b: O=C(CSc1nnc(Cn2c(=O)sc3ccccc32)n1-c1ccccc1)NCc1ccco1
c: CC1CCN(S(=O)(=O)c2ccc3[nH]c(=O)[nH]c3c2)CC1
Answer: c. CC1CCN(S(=O)(=O)c2ccc3[nH]c(=O)[nH]c3c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(S(=O)(=O)c2ccc3[nH]c(=O)[nH]c3c2)CC1
CC1CCN(S(=O)(=O)c2ccc3[nH]c(=O)[nH]c3c2)CC1
5-(4-methylpiperidin-1-yl)sulfonyl-1,3-dihydrobenzimidazol-2-one